In colorectal cancer patients, a KRAS-mutation occured at p.G12V in 26.4%, followed by p.G12D (19.2%), p.G13D [16.5% (Malapelle et al. 2021)], and p.G12C in 8.5% (Schirripa et al. 2020). Here, KRAS is linked to colorectal cancer.